Literature DB >> 2409001

Bovine alloreactive cytotoxic cells generated in vitro: target specificity in relation to BoLA phenotype.

A J Teale, W I Morrison, B M Goddeeris, C M Groocock, D A Stagg, R L Spooner.   

Abstract

Cytotoxic cells of bovine origin were generated in primary MLC using stimulator cells of BoLA w8/w11 phenotype. Bovine lymphoblasts transformed by the protozoan parasite Theileria parva parva acted as target cells in studies of the specificity of cytotoxicity. When responder cells in MLC did not share w8 or w11 with stimulator cells, cytotoxicity was evident with all targets bearing w8 or w11, or both, and was almost entirely restricted to these products of the BoLA-A locus. When responder and stimulator cells shared both w8 and w11, cytotoxicity was also generated. Whether this was specific for the products of other putative Class I loci in cattle, or for the products of a Class II region, remains to be determined. These results suggest that the determinants recognized by appropriately generated bovine alloreactive cytotoxic cells are identical with, or closely related to, determinants characterized by BoLA w8 and w11 defining alloantisera.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409001      PMCID: PMC1453610     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Biochemical characterization of class II bovine major histocompatibility complex antigens using cross-species reactive antibodies.

Authors:  M Hoang-Xuan; D Charron; M T Zilber; D Levy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

2.  Human cell-mediated cytotoxicity against modified target cells is restricted by HLA.

Authors:  E Dickmeiss; B Soeberg; A Svejgaard
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

3.  HLA restriction of cell-mediated lysis of influenza virus-infected human cells.

Authors:  A J McMichael; A Ting; H J Zweerink; B A Askonas
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

4.  The initial stages of infection of cattle cells with Theileria parva sporozoites in vitro.

Authors:  D A Stagg; T T Dolan; B L Leitch; A S Young
Journal:  Parasitology       Date:  1981-08       Impact factor: 3.234

5.  Serologically defined (SD) locus in cattle.

Authors:  B Amorena; W H Stone
Journal:  Science       Date:  1978-07-14       Impact factor: 47.728

6.  The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens.

Authors:  W E Biddison; F E Ward; G M Shearer; S Shaw
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

7.  Analysis of alloantisera against bovine lymphocytes. Joint report of the 1st International Bovine Lymphocyte Antigen (BoLA) workshop.

Authors:  R L Spooner; R A Oliver; D I Sales; C M McCoubrey; P Millar; A G Morgan; B Amorena; E Bailey; D Bernoco; M Brandon; R W Bull; J Caldwell; S Cwik; R H van Dam; J Dodd; B Gahne; F Grosclaude; J G Hall; H Hines; H Leveziel; M J Newman; M J Stear; W H Stone; M Vaiman
Journal:  Anim Blood Groups Biochem Genet       Date:  1979

8.  Bovine lymphocyte antigens (BoLA) of bovine lymphocytes and derived lymphoblastoid lines transformed by Theileria parva and Theileria annulata.

Authors:  R L Spooner; C G Brown
Journal:  Parasite Immunol       Date:  1980       Impact factor: 2.280

9.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse.

Authors:  H Wagner; D Götze; L Ptschelinzew; M Röllinghoff
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more
  7 in total

1.  Characterization by a monoclonal antibody and functional analysis of a subset of bovine T lymphocytes that express BoT8, a molecule analogous to human CD8.

Authors:  J A Ellis; C L Baldwin; N D MacHugh; A Bensaid; A J Teale; B M Goddeeris; W I Morrison
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

2.  Bovine cytotoxic T-cell clones specific for cells infected with the protozoan parasite Theileria parva: parasite strain specificity and class I major histocompatibility complex restriction.

Authors:  B M Goddeeris; W I Morrison; A J Teale; A Bensaid; C L Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Bovine alloreactive cytotoxic cells generated in vitro detect BoLA w6 subgroups.

Authors:  R L Spooner; E A Innes; P Millar; S P Simpson; J Webster; A J Teale
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

4.  Transfection into mouse L cells of genes encoding two serologically and functionally distinct bovine class I MHC molecules from a MHC-homozygous animal: evidence for a second class I locus in cattle.

Authors:  P G Toye; N D MacHugh; A M Bensaid; S Alberti; A J Teale; W I Morrison
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

5.  Adoptive transfer of immunity to Theileria parva in the CD8+ fraction of responding efferent lymph.

Authors:  D J McKeever; E L Taracha; E L Innes; N D MacHugh; E Awino; B M Goddeeris; W I Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

6.  Pathogenicity of Theileria parva is influenced by the host cell type infected by the parasite.

Authors:  W I Morrison; N D MacHugh; P A Lalor
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

7.  The bovine autologous Theileria mixed leucocyte reaction: influence of monocytes and phenotype of the parasitized stimulator cell on proliferation and parasite specificity.

Authors:  B M Goddeeris; W I Morrison
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.